Clinical Trials Directory

Trials / Completed

CompletedNCT02594046

The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Pusan National University Hospital · Academic / Other
Sex
All
Age
19 Years – 59 Years
Healthy volunteers
Accepted

Summary

This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.

Detailed description

This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.

Conditions

Interventions

TypeNameDescription
OTHERstem cell component extractThe Allogeneic Human adipose derived stem cell component extract

Timeline

Start date
2015-07-01
Primary completion
2016-02-28
Completion
2016-05-28
First posted
2015-11-02
Last updated
2017-04-05

Source: ClinicalTrials.gov record NCT02594046. Inclusion in this directory is not an endorsement.

The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia (NCT02594046) · Clinical Trials Directory